Drug Profile
Research programme: factor Xa inhibitors - Takeda
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Takeda
- Class Imidazoles; Small molecules
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombosis in Japan (PO)